2vg7: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image: | ==CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS== | ||
<StructureSection load='2vg7' size='340' side='right' caption='[[2vg7]], [[Resolution|resolution]] 2.82Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[2vg7]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VG7 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2VG7 FirstGlance]. <br> | |||
</td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NNI:O-[2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)ETHYL]+(4-IODOPHENYL)THIOCARBAMATE'>NNI</scene><br> | |||
<tr><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1ajv|1ajv]], [[1bqm|1bqm]], [[1d4h|1d4h]], [[1d4i|1d4i]], [[1dw6|1dw6]], [[1ebk|1ebk]], [[1ebw|1ebw]], [[1ec0|1ec0]], [[1ec1|1ec1]], [[1ec2|1ec2]], [[1ec3|1ec3]], [[1eet|1eet]], [[1hni|1hni]], [[1hnv|1hnv]], [[1hps|1hps]], [[1hqe|1hqe]], [[1htf|1htf]], [[1htg|1htg]], [[1hys|1hys]], [[1ikw|1ikw]], [[1mes|1mes]], [[1met|1met]], [[1n5y|1n5y]], [[1n6q|1n6q]], [[1rdh|1rdh]], [[1rtd|1rtd]], [[1ajx|1ajx]], [[1axa|1axa]], [[1bqn|1bqn]], [[1d4j|1d4j]], [[1dlo|1dlo]], [[1eby|1eby]], [[1ebz|1ebz]], [[1hbv|1hbv]], [[1hef|1hef]], [[1heg|1heg]], [[1hih|1hih]], [[1hmv|1hmv]], [[1hos|1hos]], [[1hpz|1hpz]], [[1hqu|1hqu]], [[1hrh|1hrh]], [[1hte|1hte]], [[1hvk|1hvk]], [[1hvp|1hvp]], [[1hvu|1hvu]], [[1ikv|1ikv]], [[1ikx|1ikx]], [[1iky|1iky]], [[1j5o|1j5o]], [[1mer|1mer]], [[1meu|1meu]], [[1qe1|1qe1]], [[1qmc|1qmc]], [[1rvl|1rvl]], [[1rvn|1rvn]], [[1rvr|1rvr]], [[1sbg|1sbg]], [[1t05|1t05]], [[1tvr|1tvr]], [[1uwb|1uwb]], [[1w5v|1w5v]], [[2b5j|2b5j]], [[2ban|2ban]], [[2uxz|2uxz]], [[2uy0|2uy0]], [[3hvt|3hvt]], [[3tlh|3tlh]], [[1r0a|1r0a]], [[1rvm|1rvm]], [[1rvo|1rvo]], [[1rvp|1rvp]], [[1rvq|1rvq]], [[1s6p|1s6p]], [[1s6q|1s6q]], [[1s9e|1s9e]], [[1s9g|1s9g]], [[1suq|1suq]], [[1sv5|1sv5]], [[1t03|1t03]], [[1tv6|1tv6]], [[1w5w|1w5w]], [[1w5x|1w5x]], [[1w5y|1w5y]], [[2b6a|2b6a]], [[2be2|2be2]], [[2hmi|2hmi]], [[2vg5|2vg5]], [[2vg6|2vg6]]</td></tr> | |||
<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2vg7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2vg7 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2vg7 RCSB], [http://www.ebi.ac.uk/pdbsum/2vg7 PDBsum]</span></td></tr> | |||
<table> | |||
== Evolutionary Conservation == | |||
[[Image:Consurf_key_small.gif|200px|right]] | |||
Check<jmol> | |||
<jmolCheckbox> | |||
<scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/vg/2vg7_consurf.spt"</scriptWhenChecked> | |||
<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | |||
<text>to colour the structure by Evolutionary Conservation</text> | |||
</jmolCheckbox> | |||
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/chain_selection.php?pdb_ID=2ata ConSurf]. | |||
<div style="clear:both"></div> | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
O-Phthalimidoethyl-N-arylthiocarbamates (TCs) have been recently identified as a new class of potent HIV-1 reverse transcriptase (RT) non-nucleoside inhibitors (NNRTIs), by means of computer-aided drug design techniques [Ranise A. Spallarossa, S. Cesarini, F. Bondavalli, S. Schenone, O. Bruno, G. Menozzi, P. Fossa, L. Mosti, M. La Colla, et al., Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives, J. Med. Chem. 48 (2005) 3858-3873]. To elucidate the atomic details of RT/TC interaction and validate an earlier TC docking model, the structures of three RT/TC complexes were determined at 2.8-3.0A resolution by X-ray crystallography. The conformations adopted by the enzyme-bound TCs were analyzed and compared with those of bioisosterically related NNRTIs. | |||
Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhibitors.,Spallarossa A, Cesarini S, Ranise A, Ponassi M, Unge T, Bolognesi M Biochem Biophys Res Commun. 2008 Jan 25;365(4):764-70. Epub 2007 Nov 21. PMID:18035053<ref>PMID:18035053</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
</div> | |||
==See Also== | ==See Also== | ||
*[[Reverse transcriptase|Reverse transcriptase]] | *[[Reverse transcriptase|Reverse transcriptase]] | ||
== References == | |||
== | <references/> | ||
< | __TOC__ | ||
</StructureSection> | |||
[[Category: Human immunodeficiency virus 1]] | [[Category: Human immunodeficiency virus 1]] | ||
[[Category: Bolognesi, M.]] | [[Category: Bolognesi, M.]] |
Revision as of 11:32, 29 September 2014
CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORSCRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
Structural highlights
Evolutionary Conservation![]() Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf. Publication Abstract from PubMedO-Phthalimidoethyl-N-arylthiocarbamates (TCs) have been recently identified as a new class of potent HIV-1 reverse transcriptase (RT) non-nucleoside inhibitors (NNRTIs), by means of computer-aided drug design techniques [Ranise A. Spallarossa, S. Cesarini, F. Bondavalli, S. Schenone, O. Bruno, G. Menozzi, P. Fossa, L. Mosti, M. La Colla, et al., Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives, J. Med. Chem. 48 (2005) 3858-3873]. To elucidate the atomic details of RT/TC interaction and validate an earlier TC docking model, the structures of three RT/TC complexes were determined at 2.8-3.0A resolution by X-ray crystallography. The conformations adopted by the enzyme-bound TCs were analyzed and compared with those of bioisosterically related NNRTIs. Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhibitors.,Spallarossa A, Cesarini S, Ranise A, Ponassi M, Unge T, Bolognesi M Biochem Biophys Res Commun. 2008 Jan 25;365(4):764-70. Epub 2007 Nov 21. PMID:18035053[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
|
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCA- Human immunodeficiency virus 1
- Bolognesi, M.
- Cesarini, S.
- Ponassi, M.
- Ranise, A.
- Spallarossa, A.
- Unge, T.
- Aid
- Aspartyl protease
- Capsid maturation
- Core protein
- Dna integration
- Dna recombination
- Dna-directed dna polymerase
- Endonuclease
- Hiv-1
- Hydrolase
- Lipoprotein
- Magnesium
- Membrane
- Metal-binding
- Multifunctional enzyme
- Myristate
- Non-nucleoside reverse transcriptase inhibitor
- Nuclease
- Nucleotidyltransferase
- Nucleus
- Phosphorylation
- Protease
- Reverse transcriptase
- Rna-binding
- Rna-directed dna polymerase
- Thiocarbamate
- Transferase
- Viral nucleoprotein
- Virion
- Zinc-finger